The guideline authors used data from 61 studies to provide recommendations on the use of neoadjuvant chemotherapy in patients with newly diagnosed, stage III-IV epithelial ovarian, fallopian tube, or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback